| Notice Filed with SOS |
01/19/2007 |
| Rule |
ProposedRuleAttach2007-00056.rtf |
| Additional Information |
AddInfoAttach2007-00056.rtf |
| Statutory Authority |
Section 25-1-108(1)(c)(I), C.R.S. and Section 25-1-122(1), C.R.S. |
| Description of Subjects/Issues |
Amendments to the lists of reportable diseases, Regulation 1, List B, and Regulation 3. The proposed amendments include, but are not limited to, changing the listing of Campylobacter jejuni to Campylobacter species on the list of laboratory reportable conditions; changing the listing of Cryptospridium to Cryptosporidium species on the list of laboratory reportable conditions; and changing the footnote corresponding to ?Escherichia coli O157:H7 and shiga toxin-producing Escherichia col |
| Purpose/Objective of Rule |
See the attached statement of basis and purpose. |
| Basis And Purpose |
BasisandPurposeAttachment2007-00056.rtf
|
| Regulatory analysis |
RegulatoryAnalysisAttachment2007-00056.rtf
|
| Comments |
The attached adopted rules file includes instructions and references to paragraph ID#s for the amendments. These instructions are not part of the rules and should not be published. |
| Submitted in response to issues raised by COLS/OLLS? |
No
|
| Is this rule adopted in response to recent legislation? |
|
| Hearing Date |
03/21/2007 |
| Hearing Time |
10:00 AM |
| Hearing Location |
Department of Public Health and Environment, Sabin-Cleere Conference Room, 4300 Cherry Creek Drive S., Denver, CO 80246 |
| Contact Name |
Ken Gershman, MD |
| Contact Title |
Chief, Communicable Disease Epidemiology |
| Contact Telephone |
303-692-2657 |
| Contact email |
ken.gershman@state.co.us |